MiNK Therapeutics, Inc.
INKT
$10.72
$0.212.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.76M | 1.85M | 1.85M | 1.27M | 808.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -571.10K | 193.90K | -- | -- | 287.70K |
| Total Operating Expenses | 2.71M | 3.18M | 3.69M | 2.53M | 2.50M |
| Operating Income | -2.71M | -3.18M | -3.69M | -2.53M | -2.50M |
| Income Before Tax | -2.60M | -2.89M | -4.24M | -2.77M | -2.46M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.60M | -2.89M | -4.24M | -2.77M | -2.46M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.60M | -2.89M | -4.24M | -2.77M | -2.46M |
| EBIT | -2.71M | -3.18M | -3.69M | -2.53M | -2.50M |
| EBITDA | -2.67M | -3.14M | -3.64M | -2.48M | -2.45M |
| EPS Basic | -0.56 | -0.65 | -1.06 | -0.70 | -0.62 |
| Normalized Basic EPS | -0.35 | -0.41 | -0.61 | -0.41 | -0.39 |
| EPS Diluted | -0.56 | -0.65 | -1.06 | -0.70 | -0.62 |
| Normalized Diluted EPS | -0.35 | -0.41 | -0.61 | -0.41 | -0.39 |
| Average Basic Shares Outstanding | 4.69M | 4.44M | 3.98M | 3.97M | 3.96M |
| Average Diluted Shares Outstanding | 4.69M | 4.44M | 3.98M | 3.97M | 3.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |